Ferroptosis-IN-6 is a chemical compound recognized for its role as an inhibitor of ferroptosis, a form of regulated cell death characterized by the accumulation of lipid peroxides. This compound is particularly significant in the context of cancer research and neurodegenerative diseases, where ferroptosis has been implicated in disease progression and cell death. Ferroptosis-IN-6 functions by targeting specific pathways involved in iron metabolism and lipid peroxidation, thereby modulating cellular responses to oxidative stress. The compound is typically studied in vitro and in vivo to explore its potential therapeutic applications, especially in conditions where ferroptosis contributes to pathology. Its chemical structure includes functional groups that facilitate its interaction with biological targets, enhancing its efficacy as an inhibitor. As research continues, the understanding of Ferroptosis-IN-6's mechanisms and its potential as a therapeutic agent is expected to evolve, providing insights into novel treatment strategies for diseases associated with ferroptosis.

Ferroptosis-IN-6

1517780-59-4: Ferroptosis-IN-6 is a chemical compound recognized for its role as an inhibitor of ferroptosis, a form of regulated cell death characterized by the accumulation of lipid peroxides. This compound is particularly significant in the context of cancer research and neurodegenerative diseases, where ferroptosis has been implicated in disease progression and cell death. Ferroptosis-IN-6 functions by targeting specific pathways involved in iron metabolism and lipid peroxidation, thereby modulating cellular responses to oxidative stress. The compound is typically studied in vitro and in vivo to explore its potential therapeutic applications, especially in conditions where ferroptosis contributes to pathology. Its chemical structure includes functional groups that facilitate its interaction with biological targets, enhancing its efficacy as an inhibitor. As research continues, the understanding of Ferroptosis-IN-6's mechanisms and its potential as a therapeutic agent is expected to evolve, providing insights into novel treatment strategies for diseases associated with ferroptosis.

Ferroptosis-IN-6 is an efficient ferroptosis inhibitor, protecting cells from cell death induced by ferroptosis inducers, and inhibiting STY-BODIPY oxidation.

CAS 1517780-59-4

Ferroptosis-IN-6

Ferroptosis-IN-6

Ref: 54-BUP19413

Ferroptosis-IN-6

Ref: TM-T86417